Term ended no later than Mar 13, 2026 · Medium confidence
20-year base term ended Apr 25, 2025
Apr 25, 2005
Mar 13, 2026
Feb 3, 2009
This patent's term runs 322 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 25, 2005, when this application, 11/113,486, was filed | Apr 25, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +322 days, USPTO patent term adjustment record | Mar 13, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | no later than Mar 13, 2026 | Medium confidence |
This family
| US 7,485,283 | this patent no later than Mar 2026 | no later than Mar 2026 |
| Application PCT/US2005/014459 | PCT application no patent term | no patent term |
| US 8,263,042 | In force Feb 2027 | Feb 2027 |
| Application 13/571,911 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 21, 2005 Reel 16549, frame 262 | Radeke, Heike S.; Casebier, David S.; Azure, Michael T.; Dischino, Douglas D. | Bristol-Myers Squibb Company | Assignment of Assignor's Interest |
| Sep 20, 2005 Reel 16557, frame 619 | Radeke, Heike S.; Casebier, David S.; Dischino, Douglas D.; Azure, Michael T. | Bristol-Myers Squibb Pharma Company | Corrective Assignment to Correct the Name of Assignee (OUR Error on Recordation Sheet) Previously Recorded on Reel 016549 Frame 0262. Assignor(S) Hereby Confirms the Correct Assignee Is Bristol-Myers Squibb Pharma Company. |
| Jan 9, 2008 Reel 20339, frame 341 | Bristol-Myers Squibb Pharma Company | Acp Lantern Acquisition, Inc. | Assignment of Patents |
| Mar 6, 2008 Reel 20609, frame 506 | Acp Lantern Acquisition, Inc. | Ableco Finance LLC, as Collateral Agent | Grant of Security Interest |
| Mar 7, 2008 Reel 20609, frame 733 | Acp Lantern Acquisition, Inc. | Bristol-Myers Squibb Medical Imaging, Inc. | Merger |
| Mar 7, 2008 Reel 20609, frame 746 | Bristol-Myers Squibb Medical Imaging, Inc. | Lantheus Medical Imaging, Inc. | Change of Name |
| Jan 28, 2009 Reel 22167, frame 251 | Radeke, Heike S; Casebier, David S; Azure, Michael T; Dischino, Douglas D | Bristol-Myers Squibb Pharma Company | Assignment of Assignor's Interest |
| Jan 28, 2009 Reel 22168, frame 578 | Bristol-Myers Squibb Pharma Company | Acp Lantern Acquisition, Inc. | Assignment of Assignor's Interest |
| Jan 28, 2009 Reel 22168, frame 893 | Acp Lantern Acquisition, Inc. | Bristol-Myers Squibb Medical Imaging, Inc. | Merger |
| Jan 30, 2009 Reel 22184, frame 696 | Bristol-Myers Squibb Medical Imaging, Inc. | Lantheus Medical Imaging, Inc. | Change of Name |
| May 13, 2010 Reel 24380, frame 363 | Ableco Finance LLC | Lantheus Medical Imaging, Inc. | Release of Patent Security Agreement |
| May 13, 2010 Reel 24390, frame 733 | Lantheus Medical Imaging, Inc. | Harris N.a., As Collateral Agent | Security Agreement |
| Jul 3, 2013 Reel 30740, frame 335 | BMO Harris Bank N.A. | Wells Fargo Bank, National Association, as Assignee | Assignment of Security Interest in Patents |
| Jun 30, 2015 Reel 36013, frame 516 | Lantheus Medical Imaging, Inc. | Credit Suisse AG, Cayman Islands Branch, as Collateral Agent | Security Agreement |
| Mar 30, 2017 Reel 42115, frame 715 | Wells Fargo Bank, National Association | Lantheus Holdings, Inc.; Lantheus Medical Imaging, Inc.; Lantheus Mi Real Estate, LLC | Release of Security Interest in Certain Patents |
| Mar 30, 2017 Reel 42115, frame 769 | Credit Suisse AG, Cayman Islands Branch | JPMorgan Chase Bank, N.A., as Successor Agent | Notice of Succession of Agency |
| Mar 30, 2017 reel/frame not recorded | Wells Fargo Bank, National Association | Lantheus Holdings, Inc. | Release of Security Interest in Certain Patents |
| Mar 30, 2017 reel/frame not recorded | Wells Fargo Bank, National Association | Lantheus Medical Imaging, Inc. | Release of Security Interest in Certain Patents |
| Mar 30, 2017 reel/frame not recorded | Wells Fargo Bank, National Association | Lantheus Mi Real Estate, LLC | Release of Security Interest in Certain Patents |
| Jun 27, 2019 Reel 49623, frame 123 | Jpmorgan Chase Bank, N.a. | Lantheus Medical Imaging, Inc. | Release of Security Interest |
| Jun 28, 2019 Reel 49628, frame 1 | Lantheus Medical Imaging, Inc. | Wells Fargo Bank, N.a. | Security Agreement |
| Dec 2, 2022 Reel 62047, frame 925 | Wells Fargo Bank, N.a. | Lantheus Medical Imaging, Inc. | Release of Security Interest |
| Dec 2, 2022 Reel 62047, frame 960 | Lantheus Medical Imaging, Inc.; Molecular Insight Pharmaceuticals, Inc.; Psma Development Company, LLC; Progenics Pharmaceuticals, Inc. | Citizens Bank, N.a. | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Mar 13, 2026. We will not guess the cap.